These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 19159009)
1. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. Mondal D; Singh SP; Kumar N; Joshi A; Sundar S; Das P; Siddhivinayak H; Kroeger A; Boelaert M PLoS Negl Trop Dis; 2009; 3(1):e355. PubMed ID: 19159009 [TBL] [Abstract][Full Text] [Related]
2. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal. Joshi AB; Das ML; Akhter S; Chowdhury R; Mondal D; Kumar V; Das P; Kroeger A; Boelaert M; Petzold M BMC Med; 2009 Oct; 7():54. PubMed ID: 19804620 [TBL] [Abstract][Full Text] [Related]
3. Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs. Huda MM; Hirve S; Siddiqui NA; Malaviya P; Banjara MR; Das P; Kansal S; Gurung CK; Naznin E; Rijal S; Arana B; Kroeger A; Mondal D BMC Public Health; 2012 Nov; 12():1001. PubMed ID: 23164318 [TBL] [Abstract][Full Text] [Related]
4. How do health care providers deal with kala-azar in the Indian subcontinent? Kumar N; Singh SP; Mondal D; Joshi A; Das P; Sundar S; Kroeger A; Hirve S; Siddiqui NA; Boelaert M Indian J Med Res; 2011 Sep; 134(3):349-55. PubMed ID: 21985818 [TBL] [Abstract][Full Text] [Related]
5. Barriers of Visceral Leishmaniasis reporting and surveillance in Nepal: comparison of governmental VL-program districts with non-program districts. Lim D; Banjara MR; Singh VK; Joshi AB; Gurung CK; Das ML; Matlashewski G; Olliaro P; Kroeger A Trop Med Int Health; 2019 Feb; 24(2):192-204. PubMed ID: 30565348 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Hirve S; Singh SP; Kumar N; Banjara MR; Das P; Sundar S; Rijal S; Joshi A; Kroeger A; Varghese B; Thakur CP; Huda MM; Mondal D Am J Trop Med Hyg; 2010 Sep; 83(3):507-11. PubMed ID: 20810811 [TBL] [Abstract][Full Text] [Related]
7. Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India. Boettcher JP; Siwakoti Y; Milojkovic A; Siddiqui NA; Gurung CK; Rijal S; Das P; Kroeger A; Banjara MR BMC Infect Dis; 2015 Feb; 15():43. PubMed ID: 25656298 [TBL] [Abstract][Full Text] [Related]
8. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. Singh SP; Hirve S; Huda MM; Banjara MR; Kumar N; Mondal D; Sundar S; Das P; Gurung CK; Rijal S; Thakur CP; Varghese B; Kroeger A PLoS Negl Trop Dis; 2011 Feb; 5(2):e960. PubMed ID: 21347452 [TBL] [Abstract][Full Text] [Related]
9. Kala-azar elimination in a highly-endemic district of Bihar, India: A success story. Kumar V; Mandal R; Das S; Kesari S; Dinesh DS; Pandey K; Das VR; Topno RK; Sharma MP; Dasgupta RK; Das P PLoS Negl Trop Dis; 2020 May; 14(5):e0008254. PubMed ID: 32365060 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study. Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216 [TBL] [Abstract][Full Text] [Related]
11. Positive Influence of Behavior Change Communication on Knowledge, Attitudes, and Practices for Visceral Leishmaniasis/Kala-azar in India. Srinivasan R; Ahmad T; Raghavan V; Kaushik M; Pathak R Glob Health Sci Pract; 2018 Mar; 6(1):192-209. PubMed ID: 29386327 [TBL] [Abstract][Full Text] [Related]
12. Accelerated active case detection of visceral leishmaniasis patients in endemic villages of Bangladesh. Khatun J; Huda MM; Hossain MS; Presber W; Ghosh D; Kroeger A; Matlashewski G; Mondal D PLoS One; 2014; 9(8):e103678. PubMed ID: 25090412 [TBL] [Abstract][Full Text] [Related]
13. Entomological efficacy of durable wall lining with reduced wall surface coverage for strengthening visceral leishmaniasis vector control in Bangladesh, India and Nepal. Huda MM; Kumar V; Das ML; Ghosh D; Priyanka J; Das P; Alim A; Matlashewski G; Kroeger A; Alfonso-Sierra E; Mondal D BMC Infect Dis; 2016 Oct; 16(1):539. PubMed ID: 27716091 [TBL] [Abstract][Full Text] [Related]
14. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India. Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal. Joshi AB; Banjara MR; Chuke S; Kroeger A; Jain S; Aseffa A; Reeder JC PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011714. PubMed ID: 37943733 [TBL] [Abstract][Full Text] [Related]
16. Molecular evidence supports the expansion of visceral leishmaniasis towards non-program districts of Nepal. Shrestha M; Khatri-Chhetri M; Poudel RC; Maharjan J; Dumre SP; Manandhar KD; Pandey BD; Pun SB; Pandey K BMC Infect Dis; 2019 May; 19(1):444. PubMed ID: 31113385 [TBL] [Abstract][Full Text] [Related]
17. Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India. Bulstra CA; Le Rutte EA; Malaviya P; Hasker EC; Coffeng LE; Picado A; Singh OP; Boelaert MC; de Vlas SJ; Sundar S PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006888. PubMed ID: 30521529 [TBL] [Abstract][Full Text] [Related]
18. Epidemiological, serological, and entomological aspects of visceral leishmaniasis (VL) in suspected new VL foci in Bangladesh. Ghosh D; Rashid MU; Sagar SK; Uddin MR; Maruf S; Ghosh P; Chowdhury R; Rahat MA; Islam MN; Aktaruzzaman MM; Sohel ANM; Banjara MR; Kroeger A; Aseffa A; Mondal D Acta Trop; 2023 Dec; 248():107021. PubMed ID: 37716668 [TBL] [Abstract][Full Text] [Related]
19. Modelling spatiotemporal patterns of visceral leishmaniasis incidence in two endemic states in India using environment, bioclimatic and demographic data, 2013-2022. Subramanian S; Maheswari RU; Prabavathy G; Khan MA; Brindha B; Srividya A; Kumar A; Rahi M; Nightingale ES; Medley GF; Cameron MM; Roy N; Jambulingam P PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011946. PubMed ID: 38315725 [TBL] [Abstract][Full Text] [Related]
20. Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010. Picado A; Dash AP; Bhattacharya S; Boelaert M Indian J Med Res; 2012 Jul; 136(1):22-31. PubMed ID: 22885260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]